Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Island Pharmaceuticals Ltd ( (AU:ILA) ) has issued an announcement.
Island Pharmaceuticals Ltd has announced a change in the director’s interest, with Phillip Lynch exercising 80,000 options at $0.06 each, valued at $4,800. This change increases Lynch’s holdings to 340,000 fully paid ordinary shares and maintains his 3,000,000 options, potentially impacting the company’s governance and shareholder dynamics.
More about Island Pharmaceuticals Ltd
Island Pharmaceuticals Ltd operates in the pharmaceutical industry, focusing on the development and commercialization of innovative therapies. The company is dedicated to addressing unmet medical needs and enhancing patient care through its research and development efforts.
YTD Price Performance: 2.94%
Average Trading Volume: 143,317
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$33.61M
Learn more about ILA stock on TipRanks’ Stock Analysis page.